Oberweis Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Buy
158,502
+9,901
+7% +$1.02M 0.31% 112
2026
Q1
$16.2M Buy
148,601
+32,300
+28% +$3.08M 0.48% 83
2025
Q4
$9.43M Buy
116,301
+2,534
+2% +$218K 0.34% 108
2025
Q3
$9.96M Sell
113,767
-899
-0.8% -$80.3K 0.38% 99
2025
Q2
$9.52M Buy
114,666
+12,601
+12% +$1.05M 0.41% 86
2025
Q1
$8.56M Sell
102,065
-240
-0.2% -$22.3K 0.43% 84
2024
Q4
$9.43M Buy
102,305
+1,601
+2% +$154K 0.44% 86
2024
Q3
$9.35M Buy
100,704
+1
+0% +$87 0.48% 82
2024
Q2
$8.29M Buy
100,703
+20,702
+26% +$1.52M 0.51% 76
2024
Q1
$5.31M Buy
80,001
+14,701
+23% +$907K 0.38% 103
2023
Q4
$3.71M Buy
65,300
+8,300
+15% +$435K 0.35% 114
2023
Q3
$3.11M Buy
57,000
+25,400
+80% +$1.51M 0.33% 119
2023
Q2
$2.13M Buy
31,600
+2,900
+10% +$177K 0.26% 127
2023
Q1
$1.48M Buy
28,700
+7,100
+33% +$345K 0.23% 137
2022
Q4
$994K Buy
21,600
+7,300
+51% +$342K 0.21% 133
2022
Q3
$725K Buy
+14,300
New +$715K 0.17% 134

Other funds holding LMAT

Oberweis Asset Management's LMAT Position: Q2 2026 in Review

Oberweis Asset Management increased its LeMaitre Vascular (LMAT) stake by 6.7% in Q2 2026, buying an estimated $1.02M and bringing the position to 158,502 shares worth $15.2M. The position accounts for 0.31% of the portfolio, ranked #112.

Oberweis Asset Management first reported a position in LMAT in Q3 2022 and has held it in 16 quarters since. The position peaked at $16.2M in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Oberweis Asset Management held 158,502 shares of LeMaitre Vascular worth $15.2M as of Q2 2026.
  • Oberweis Asset Management bought 9,901 LeMaitre Vascular shares in Q2 2026, an estimated $1.02M.
  • LeMaitre Vascular made up 0.31% of Oberweis Asset Management's portfolio in Q2 2026, its #112 holding.
  • Oberweis Asset Management first reported a position in LeMaitre Vascular in Q3 2022 and has held it in 16 quarters since.
  • Oberweis Asset Management's LeMaitre Vascular position peaked at $16.2M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.